Fig. 1From: Co-mutations of TP53 and KRAS serve as potential biomarkers for immune checkpoint blockade in squamous-cell non-small cell lung cancer: a case reportCT scans of the patient. a, c CT scan before lobectomy. Two masses in the left lower lung lobe were noted; and b, d CT scan after lobectomyBack to article page